Visitor Count :5305819
40th Anniversary Celebration
Research & Publications > The Hong Kong Practitioner > MCQ

MCQ (Please login 'Member Area' for online submission of latest issue)

MCQ June 2018

1. Which of the following chronic condition has the strongest association with Multi-morbidity as noted in the paper titled “A study of the prevalence of Multi-morbidities among public primary healthcare services in the New Territories West area of Hong Kong”?

A. Depression.
B. Diabetes.
C. Chronic Kidney Disease.
D. Psoriasis.
E. Schizophrenia.

Answer: B.


2. Which of the following tool(s) could be used to measure Multi-morbidity?

A. Clinician Rated Disease Count.
B. Cumulative Illness Rating Scale.
C. Centor score.
D. A and B.
E. A, B and C.

Answer: D.


3. The following statements related to the new classification criteria (2010 ACR/ELAR) for Rheumatoid Arthritis (RA) is correct EXCEPT:

A. Patients have at least 1 joint with clinical synovitis and the synovitis is not better explained by other diseases.
B. The criteria do not rely on radiographic changes for diagnosis.
C. Patients with erosive disease typical of rheumatoid arthritis with a history compatible with prior fulfillment of 2010 criteria should be classified as having RA.
D. A score of 4/10 is indicative of the presence of definite RA.
E. It facilitates the assessment of early stage of arthritis and serves as the basis for starting DMARDs.

Answer: D.


4. Which ONE of the following statements regarding management of Rheumatoid Arthritis is INCORRECT?

A. RA patients should be screened for bone mineral density as they are high-risk group for fragility fracture and osteoporosis.
B. Patients who are currently taking biological drugs are recommended for herpes zoster vaccination.
C. Disease remission (i.e. DAS28 < 2.6) had become the accepted treatment goal to arrest joint damage.
D. Hydroxychloroquine can cause retinal toxicity and hence we need to monitor visual symptoms for patients on this drug.
E. Pneumonitis is one of the side effects of methotrexate.

Answer: B.


5. The followings are common sites of fixed drug eruption EXCEPT:

A. Scalp.
B. Genitalia.
C. Lips.
D. Feet.
E. Trunk.

Answer: A.


6. Which of the following is known NOT to be a causative agent of fixed drug eruption?

A. Nitrofurantoin.
B. Etoricoxib.
C. Paracetamol.
D. Hydroxyzine.
E. None of the above.

Answer: E.


Back